According to the Hong Kong Ta Kung Pao report, Superstar International announced that it intends to acquire a 70% stake in Guangzhou Hongen Medical Diagnostics Technology, which is engaged in the sales and distribution of medical equipment for the in-vitro diagnostic industry, for a consideration of RMB 336 million. The consideration will be through internal cash resources. Or you can use bank credit to pay in cash. Upon completion of the transaction, Hong En will become an indirect non-wholly owned subsidiary of Superstar.
Hong En's newly established limited liability company in China on September 6 last year, its business scope includes medical device franchise business (according to the "Medical Device Business Enterprise License"), registered capital of 20 million yuan, holding effective medical care The device business license, and the second type of medical device that is required to operate the medical device business license.
For the acquisition, the Superstar Board of Directors believes that the acquisition provides the Group with valuable business opportunities to expand its presence in the Chinese healthcare industry and expand the Group's product portfolio through expansion and diversification to broaden the Group's revenue base in the long run. . The Board believes that the acquisition of Hong En will help the Group expand its market share in the medical equipment and consumable products market in China and the Group's product portfolio.
Medton Medical , https://www.medtonmedical.com